Ownership history in NATIXIS · 7 quarters on record
This page tracks every 13F SEC filing in which NATIXIS reported a position in ADAPTIVE BIOTECHNOLOGIES COR (ADPT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 47,600 | -109,874 | -69.8% | 0.00% | $712K | $14.96 |
| 2022 Q1 | ADDED | 157,474 | +151,569 | +2566.8% | 0.01% | $2.2M | $13.88 |
| 2021 Q3 | REDUCED | 5,905 | -47 | -0.8% | 0.00% | $201K | $33.99 |
| 2021 Q2 | REDUCED | 5,952 | -62,122 | -91.3% | 0.00% | $243K | $40.86 |
As of 2025 Q4 — sorted by position size